Clinical Trial Update: Study In Patients With Insulin Resistance [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating a treatment for insulin resistance has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance

Snippet

Sponsor: GlaxoSmithKline | Conditions: Insulin Resistance | Phase 3 | Status: COMPLETED